▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3626 by analyst upside · 2026-11-12
VEEV
Veeva Systems Inc.
Healthcare · Market Cap $49B · P/E 50.1x
ANALYST PRICE TARGET
+6.0%
implied upside to consensus target
Current Price $304.77
Consensus Target $323.07
Bull Target $375.0
Bear Target $180.0
Analysts Covering 27
ANALYST CONSENSUS - BUY
Strong Buy
7
Buy
12
Hold
7
Sell
1
52-Week Low $148.05
52-Week High $325.99
YTD Return +38.9%
FUNDAMENTALS
Market Cap $49B
P/E Ratio (TTM) 50.1x
Forward P/E 29.7x
EPS (TTM) $6.08
PEG Ratio 1.18
Dividend Yield N/A
Revenue (TTM) $3.5B
Profit Margin 29.3%
52-WEEK RANGE
52-Week Low $148.05
52-Week High $325.99
Current Price $304.77
Bear Target $180.0
Bull Target $375.0
● Now $304.77 ● Target $323.07
TRADING DATA
Avg Volume 1.6M
YTD Return +38.9%
Analyst Count 27
Consensus Buy
Upside to Target +6.0%
Last Updated 2026-11-12

ANALYST SUMMARY

Veeva Systems Inc. (VEEV) is currently trading at $304.77 with a Wall Street consensus price target of $323.07, implying potential upside of 6.0% over the next 12 months. 27 analysts currently cover VEEV, with a consensus rating of Buy - 70% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $375.0, while the most cautious has a target of $180.0.

VEEV operates in the Healthcare sector with a market capitalisation of $49B. The stock is up 38.9% year-to-date and is currently trading near the upper end of its 52-week range of $148.05 – $325.99.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for VEEV, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Overweight → Overweight 2026-10-28 Building track record
Baird - Reiterated
Outperform → Outperform 2026-10-26 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-10-19 Building track record
Citigroup - Reiterated
Neutral → Neutral 2026-08-28 Building track record
Mizuho - Reiterated
Outperform → Outperform 2026-08-27 Building track record
BMO Capital - Reiterated
Market Perform → Market Perform 2026-08-27 Building track record
Baird - Reiterated
Outperform → Outperform 2026-08-27 Building track record
Canaccord Genuity - Reiterated
Hold → Hold 2026-08-27 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
56
out of 100
Coverage depth
25/30
Consensus clarity
17/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →